194 related articles for article (PubMed ID: 11685189)
21. A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar.
Momtazi M; Kwan P; Ding J; Anderson CC; Honardoust D; Goekjian S; Tredget EE
Wound Repair Regen; 2013; 21(1):77-87. PubMed ID: 23126488
[TBL] [Abstract][Full Text] [Related]
22. Nerve outgrowth and neuropeptide expression during the remodeling of human burn wound scars. A 7-month follow-up study of 22 patients.
Altun V; Hakvoort TE; van Zuijlen PP; van der Kwast TH; Prens EP
Burns; 2001 Nov; 27(7):717-22. PubMed ID: 11600251
[TBL] [Abstract][Full Text] [Related]
23. Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue.
Jeong HS; Lee BH; Sung HM; Park SY; Ahn DK; Jung MS; Suh IS
Plast Reconstr Surg; 2015 Aug; 136(2):171e-178e. PubMed ID: 26218391
[TBL] [Abstract][Full Text] [Related]
24. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
25. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors.
Moulin V; Larochelle S; Langlois C; Thibault I; Lopez-Vallé CA; Roy M
J Cell Physiol; 2004 Mar; 198(3):350-8. PubMed ID: 14755540
[TBL] [Abstract][Full Text] [Related]
26. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma.
Akasaka Y; Fujita K; Ishikawa Y; Asuwa N; Inuzuka K; Ishihara M; Ito M; Masuda T; Akishima Y; Zhang L; Ito K; Ishii T
Wound Repair Regen; 2001; 9(6):501-6. PubMed ID: 11896992
[TBL] [Abstract][Full Text] [Related]
27. Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study.
Pittet B; Rubbia-Brandt L; Desmoulière A; Sappino AP; Roggero P; Guerret S; Grimaud JA; Lacher R; Montandon D; Gabbiani G
Plast Reconstr Surg; 1994 May; 93(6):1224-35. PubMed ID: 8171142
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
29. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
[TBL] [Abstract][Full Text] [Related]
30. Expression and localization of insulin-like growth factor-1 in normal and post-burn hypertrophic scar tissue in human.
Ghahary A; Shen YJ; Wang R; Scott PG; Tredget EE
Mol Cell Biochem; 1998 Jun; 183(1-2):1-9. PubMed ID: 9655173
[TBL] [Abstract][Full Text] [Related]
31. Within-Patient, Single-Blinded, Randomized Controlled Clinical Trial to Evaluate the Efficacy of Triamcinolone Acetonide Injections for the Treatment of Hypertrophic Scar in Adult Burn Survivors.
Nedelec B; LaSalle L; de Oliveira A; Correa JA
J Burn Care Res; 2020 Jul; 41(4):761-769. PubMed ID: 32303737
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of Langerhans cells in normal and pathological human scars. II. Hypertrophic scars.
Cracco C; Stella M; Teich Alasia S; Filogamo G
Eur J Histochem; 1992; 36(1):53-65. PubMed ID: 1374665
[TBL] [Abstract][Full Text] [Related]
33. Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues.
Castagnoli C; Trombotto C; Ondei S; Stella M; Calcagni M; Magliacani G; Alasia ST
Burns; 1997; 23(7-8):565-72. PubMed ID: 9568325
[TBL] [Abstract][Full Text] [Related]
34. Post-burn hypertrophic scars are characterized by high levels of IL-1β mRNA and protein and TNF-α type I receptors.
Salgado RM; Alcántara L; Mendoza-Rodríguez CA; Cerbón M; Hidalgo-González C; Mercadillo P; Moreno LM; Alvarez-Jiménez R; Krötzsch E
Burns; 2012 Aug; 38(5):668-76. PubMed ID: 22226222
[TBL] [Abstract][Full Text] [Related]
35. Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars.
Lapthorn AR; Ilg MM; Dziewulski P; Cellek S
Eur J Pharmacol; 2024 Mar; 967():176369. PubMed ID: 38325796
[TBL] [Abstract][Full Text] [Related]
36. Expression and role of IL-15 in post-burn hypertrophic scars.
Castagnoli C; Trombotto C; Ariotti S; Millesimo M; Ravarino D; Magliacani G; Ponzi AN; Stella M; Teich-Alasia S; Novelli F; Musso T
J Invest Dermatol; 1999 Aug; 113(2):238-45. PubMed ID: 10469310
[TBL] [Abstract][Full Text] [Related]
37. The correlation of in vivo burn scar contraction with the level of α-smooth muscle actin expression.
Wang XQ; Kravchuk O; Winterford C; Kimble RM
Burns; 2011 Dec; 37(8):1367-77. PubMed ID: 21855218
[TBL] [Abstract][Full Text] [Related]
38. Mechanical forces induce scar remodeling. Study in non-pressure-treated versus pressure-treated hypertrophic scars.
Costa AM; Peyrol S; Pôrto LC; Comparin JP; Foyatier JL; Desmoulière A
Am J Pathol; 1999 Nov; 155(5):1671-9. PubMed ID: 10550323
[TBL] [Abstract][Full Text] [Related]
39. Effect of in vitro mechanical compression on Epilysin (matrix metalloproteinase-28) expression in hypertrophic scars.
Renò F; Sabbatini M; Stella M; Magliacani G; Cannas M
Wound Repair Regen; 2005; 13(3):255-61. PubMed ID: 15953044
[TBL] [Abstract][Full Text] [Related]
40. Comparison of combination therapy (steroid, calcium channel blocker, and interferon) with steroid monotherapy for treating human hypertrophic scars in an animal model.
Yang SY; Yang JY; Hsiao YC
Ann Plast Surg; 2015 May; 74 Suppl 2():S162-7. PubMed ID: 25730453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
